Technical Analysis for TYRA - Tyra Biosciences, Inc.

Grade Last Price % Change Price Change
C 18.75 2.85% 0.52
TYRA closed up 11.57 percent on Monday, October 18, 2021, on 17 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical TYRA trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 2.85%
Hot IPO Pullback Bullish Swing Setup 2.85%
Outside Day Range Expansion 2.85%
Wide Bands Range Expansion 2.85%
20 DMA Resistance Bearish 14.75%
Narrow Range Bar Range Contraction 14.75%
Wide Bands Range Expansion 14.75%
20 DMA Resistance Bearish 15.24%
Shooting Star Candlestick Bearish 15.24%
Narrow Range Bar Range Contraction 15.24%
Older End-of-Day Signals for TYRA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 18 minutes ago
Up 3% about 2 hours ago
Up 2% about 2 hours ago
60 Minute Opening Range Breakout about 3 hours ago
Down 1% about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Tumor Cell Biology Tyrosine Kinase Receptors Bladder Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor Clusters Of Differentiation Preclinical Stage Biopharmaceutical

Is TYRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.9
52 Week Low 12.7
Average Volume 405,092
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 16.64
10-Day Moving Average 15.68
Average True Range 2.50
ADX 0.0
+DI 16.47
-DI 16.00
Chandelier Exit (Long, 3 ATRs) 17.01
Chandelier Exit (Short, 3 ATRs) 20.19
Upper Bollinger Bands 19.81
Lower Bollinger Band 13.47
Percent B (%b) 0.75
BandWidth 38.11
MACD Line -0.85
MACD Signal Line -1.02
MACD Histogram 0.1718
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.82
Resistance 3 (R3) 21.42 19.82 21.22
Resistance 2 (R2) 19.82 18.91 20.02 21.02
Resistance 1 (R1) 19.03 18.35 19.43 19.43 20.82
Pivot Point 17.43 17.43 17.63 17.63 17.43
Support 1 (S1) 16.64 16.52 17.04 17.04 15.64
Support 2 (S2) 15.04 15.96 15.24 15.44
Support 3 (S3) 14.25 15.04 15.24
Support 4 (S4) 14.65